#BEGIN_DRUGCARD DB01910

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C15H23N7O5

# Chemical_IUPAC_Name:
(2R,5R)-2,5-diamino-6-[(2S,3R,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]hexanoic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Antibiotics, Antifungal
Antimalarials
Antiprotozoal Agents

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Adenosyl-Ornithine

# HET_ID:
SFG

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C15H23N7O5/c16-6(1-2-7(17)15(25)26)3-8-10(23)11(24)14(27-8)22-5-21-9-12(18)19-4-20-13(9)22/h4-8,10-11,14,23-24H,1-3,16-17H2,(H,25,26)(H2,18,19,20)/t6-,7-,8+,10+,11-,14-/m1/s1

# InChI_Key:
InChIKey=LMXOHSDXUQEUSF-CMDGEXLLSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
1910

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
381.387

# Molecular_Weight_Mono:
381.176066881

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1XDU

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-3

# Predicted_LogS:
-1.9

# Predicted_Water_Solubility:
4.63e+00 g/l

# Primary_Accession_No:
DB01910

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
46936257

# PubChem_Substance_ID:
46508037

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT02890

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
N[C@H](CC[C@@H](N)C(O)=O)C[C@@H]1O[C@H]([C@H](O)[C@H]1O)N1C=NC2=C1N=CN=C2N

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:20:36 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
Not Available

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
U10405

# Drug_Target_1_GenBank_ID_Protein:
Not Available

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
rdmB

# Drug_Target_1_Gene_Sequence:
>1125 bp
GTGAGCTCTTCCTCACCCGGGGAACCCCTGGAACCGACCGACCAGGACCTCGACGTACTC
CTGAAGAACCTCGGCAATCTGGTGACCCCGATGGCCCTGAGGGTCGCCGCGACACTCCGC
CTGGTCGATCACCTGCTGGCCGGAGCCGACACCCTCGCCGGCCTCGCCGACCGTACGGAC
ACCCATCCCCAGGCGCTCTCCCGCCTGGTCCGGCACCTGACCGTCGTCGGCGTCCTGGAG
GGCGGCGAGAAGCAGGGCCGGCCGCTGCGCCCCACCCGGCTCGGGATGCTCCTCGCCGAC
GGCCACCCGGCCCAGCAGCGGGCCTGGCTGGACCTGAACGGGGCCGTCTCCCACGCCGAC
CTGGCCTTCACCGGGCTCCTCGACGTGGTCCGCACCGGCCGCCCCGCCTACGCCGGGCGG
TACGGGCGGCCCTTCTGGGAGGACCTCTCGGCGGACGTGGCGCTGGCCGACTCCTTCGAC
GCGCTCATGTCCTGCGACGAGGACCTGGCCTACGAGGCCCCGGCCGACGCGTACGACTGG
TCGGCGGTCCGGCACGTCCTCGACGTGGGCGGCGGCAACGGCGGCATGCTCGCGGCGATC
GCCCTGCGGGCCCCGCACCTGCGCGGCACCCTGGTCGAACTGGCCGGTCCCGCCGAGCGC
GCCCGGCGCAGGTTCGCGGACGCCGGTCTGGCCGACCGGGTCACGGTGGCGGAGGGCGAC
TTCTTCAAGCCGCTGCCCGTCACCGCCGACGTCGTCCTGCTGTCGTTCGTCCTGCTCAAC
TGGTCCGACGAGGACGCGCTGACGATCCTGCGCGGCTGCGTCAGGGCGCTGGAGCCGGGA
GGCAGGCTCCTGGTCCTCGACCGTGCCGATGTCGAGGGGGACGGCGCCGACCGGTTCTTC
AGCACGCTGCTCGACCTGCGGATGCTGACGTTCATGGGCGGACGGGTGCGCACCCGGGAC
GAGGTCGTGGACCTGGCCGGATCGGCCGGACTCGCCCTGGCCTCGGAGCGCACGAGCGGC
TCCACGACCCTCCCGTTCGACTTCTCGATCCTCGAGTTCACGGCCGTCTCCGAGGAAGCG
GCCCCGGCCGCCCAGGCCTCCGAAGCCCTCCCAGCACAGGAGTAG

# Drug_Target_1_General_Function:
Involved in O-methyltransferase activity

# Drug_Target_1_General_References:
7751313	Niemi J, Mantsala P: Nucleotide sequences and expression of genes from Streptomyces purpurascens that cause the production of new anthracyclines in Streptomyces galilaeus. J Bacteriol. 1995 May;177(10):2942-5.
8081500	Niemi J, Ylihonko K, Hakala J, Parssinen R, Kopio A, Mantsala P: Hybrid anthracycline antibiotics: production of new anthracyclines by cloned genes from Streptomyces purpurascens in Streptomyces galilaeus. Microbiology. 1994 Jun;140 ( Pt 6):1351-8.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
4327

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
39797

# Drug_Target_1_Name:
RdmB

# Drug_Target_1_Number_of_Residues:
374

# Drug_Target_1_PDB_ID:
1R00

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00891	Methyltransf_2

# Drug_Target_1_Protein_Sequence:
>RdmB
MSSSSPGEPLEPTDQDLDVLLKNLGNLVTPMALRVAATLRLVDHLLAGADTLAGLADRTD
THPQALSRLVRHLTVVGVLEGGEKQGRPLRPTRLGMLLADGHPAQQRAWLDLNGAVSHAD
LAFTGLLDVVRTGRPAYAGRYGRPFWEDLSADVALADSFDALMSCDEDLAYEAPADAYDW
SAVRHVLDVGGGNGGMLAAIALRAPHLRGTLVELAGPAERARRRFADAGLADRVTVAEGD
FFKPLPVTADVVLLSFVLLNWSDEDALTILRGCVRALEPGGRLLVLDRADVEGDGADRFF
STLLDLRMLTFMGGRVRTRDEVVDLAGSAGLALASERTSGSTTLPFDFSILEFTAVSEEA
APAAQASEALPAQE

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Not Available

# Drug_Target_1_SwissProt_ID:
Q54527

# Drug_Target_1_SwissProt_Name:
Q54527_9ACTO

# Drug_Target_1_Synonyms:
Not Available

# Drug_Target_1_Theoretical_pI:
4.48

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Not Available

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
Not Available

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
M13761

# Drug_Target_2_GenBank_ID_Protein:
Not Available

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
ermC'

# Drug_Target_2_Gene_Sequence:
>735 bp
ATGAACGAGAAAAATATAAAACACAGTCAAAACTTTATTACTTCAAAACATAATATAGAT
AAAATAATGACAAATATAAGATTAAATGAACATGATAATATCTTTGAAATCGGCTCAGGA
AAAGGGCATTTTACCCTTGAATTAGTACAGAGGTGTAATTTCGTAACTGCCATTGAAATA
GACCATAAATTATGCAAAACTACAGAAAATAAACTTGTTGATCACGATAATTTCCAAGTT
TTAAACAAGGATATATTGCAGTTTAAATTTCCTAAAAACCAATCCTATAAAATATTTGGT
AATATACCTTATAACATAAGTACGGATATAATACGCAAAATTGTTTTTGATAGTATAGCT
GATGAGATTTATTTAATCGTGGAATACGGGTTTGCTAAAAGATTATTAAATACAAAACGC
TCATTGGCATTATTTTTAATGGCAGAAGTTGATATTTCTATATTAAGTATGGTTCCAAGA
GAATATTTTCATCCTAAACCTAAAGTGAATAGCTCACTTATCAGATTAAATAGAAAAAAA
TCAAGAATATCACACAAAGATAAACAGAAGTATAATTATTTCGTTATGAAATGGGTTAAC
AAAGAATACAAGAAAATATTTACAAAAAATCAATTTAACAATTCCTTAAAACATGCAGGA
ATTGACGATTTAAACAATATTAGCTTTGAACAATTCTTATCTCTTTTCAATAGCTATAAA
TTATTTAATAAGTAA

# Drug_Target_2_General_Function:
Involved in rRNA (adenine-N6,N6-)-dimethyltransferase activity

# Drug_Target_2_General_References:
10366505	Schluckebier G, Zhong P, Stewart KD, Kavanaugh TJ, Abad-Zapatero C: The 2.2 A structure of the rRNA methyltransferase ErmC' and its complexes with cofactor and cofactor analogs: implications for the reaction mechanism. J Mol Biol. 1999 Jun 4;289(2):277-91.
3087948	Monod M, Denoya C, Dubnau D: Sequence and properties of pIM13, a macrolide-lincosamide-streptogramin B resistance plasmid from Bacillus subtilis. J Bacteriol. 1986 Jul;167(1):138-47.
7543473	Zhong P, Pratt SD, Edalji RP, Walter KA, Holzman TF, Shivakumar AG, Katz L: Substrate requirements for ErmC' methyltransferase activity. J Bacteriol. 1995 Aug;177(15):4327-32.
9585521	Bussiere DE, Muchmore SW, Dealwis CG, Schluckebier G, Nienaber VL, Edalji RP, Walter KA, Ladror US, Holzman TF, Abad-Zapatero C: Crystal structure of ErmC', an rRNA methyltransferase which mediates antibiotic resistance in bacteria. Biochemistry. 1998 May 19;37(20):7103-12.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
4310

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
28908

# Drug_Target_2_Name:
rRNA adenine N-6-methyltransferase

# Drug_Target_2_Number_of_Residues:
244

# Drug_Target_2_PDB_ID:
1QAQ

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF00398	RrnaAD

# Drug_Target_2_Protein_Sequence:
>rRNA adenine N-6-methyltransferase
MNEKNIKHSQNFITSKHNIDKIMTNIRLNEHDNIFEIGSGKGHFTLELVQRCNFVTAIEI
DHKLCKTTENKLVDHDNFQVLNKDILQFKFPKNQSYKIFGNIPYNISTDIIRKIVFDSIA
DEIYLIVEYGFAKRLLNTKRSLALFLMAEVDISILSMVPREYFHPKPKVNSSLIRLNRKK
SRISHKDKQKYNYFVMKWVNKEYKKIFTKNQFNNSLKHAGIDDLNNISFEQFLSLFNSYK
LFNK

# Drug_Target_2_Reaction:
Not Available

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
This protein produces a dimethylation of the adenine residue at position 2058 in 23S rRNA, resulting in reduced affinity between ribosomes and macrolide-lincosamide-streptogramin B antibiotics

# Drug_Target_2_SwissProt_ID:
P13956

# Drug_Target_2_SwissProt_Name:
ERM_BACSU

# Drug_Target_2_Synonyms:
EC 2.1.1.48
Erythromycin resistance protein
Macrolide- lincosamide-streptogramin B resistance protein

# Drug_Target_2_Theoretical_pI:
10.20

# Drug_Target_2_Transmembrane_Regions:
None

# Drug_Target_3_Cellular_Location:
Cytoplasmic

# Drug_Target_3_Chromosome_Location:
Not Available

# Drug_Target_3_Drug_References:
Not Available

# Drug_Target_3_Essentiality:
Non-Essential

# Drug_Target_3_GenAtlas_ID:
Not Available

# Drug_Target_3_GenBank_ID_Gene:
M76681

# Drug_Target_3_GenBank_ID_Protein:
Not Available

# Drug_Target_3_GeneCard_ID:
Not Available

# Drug_Target_3_Gene_Name:
taqIM

# Drug_Target_3_Gene_Sequence:
>1266 bp
ATGGGCCTGCCACCCCTTCTGTCCTTACCTTCCAACTCCGCCCCCAGGAGCCTGGGCCGG
GTGGAGACCCCCCCGGAGGTGGTGGACTTCATGGTCTCCCTGGCCGAGGCGCCCAGGGGG
GGAAGGGTGCTGGAGCCCGCCTGCGCCCATGGGCCCTTCCTCCGGGCTTTCCGGGAGGCC
CACGGGACGGGCTACCGCTTCGTGGGGGTGGAGATAGACCCAAAAGCCCTGGACCTCCCC
CCCTGGGCCGAGGGCATCCTGGCGGACTTCCTCCTCTGGGAGCCGGGGGAGGCCTTTGAC
CTGATCCTGGGCAATCCGCCTTACGGCATCGTAGGAGAAGCCAGCAAATACCCCATTCAC
GTCTTCAAAGCGGTCAAGGACCTCTACAAGAAGGCCTTTTCCACCTGGAAGGGCAAGTAC
AACTTGTACGGGGCCTTTCTTGAAAAGGCCGTTCGCCTTCTTAAGCCTGGTGGGGTCCTC
GTCTTTGTAGTCCCGGCCACCTGGCTTGTCCTGGAGGATTTTGCCCTCCTTCGCGAGTTC
CTTGCCCGGGAAGGGAAAACATCTGTATACTACCTTGGCGAGGTTTTCCCGCAAAAAAAG
GTTAGCGCTGTAGTGATTCGCTTCCAGAAGAGCGGAAAAGGCCTTTCACTTTGGGATACC
CAAGAAAGCGAAAGCGGGTTCACGCCCATCCTCTGGGCTGAATATCCACATTGGGAAGGA
GAGATTATCCGCTTTGAAACAGAGGAGACGCGGAAGCTGGAAATATCGGGAATGCCACTG
GGAGACCTCTTTCATATCCGCTTCGCCGCAAGAAGCCCTGAATTCAAGAAACATCCAGCA
GTGAGAAAGGAACCGGGGCCAGGTCTTGTGCCTGTGCTCACAGGAAGAAATTTAAAGCCG
GGGTGGGTAGATTACGAGAAAAACCACTCCGGGCTTTGGATGCCCAAGGAAAGGGCCAAG
GAGCTCAGGGACTTCTATGCCACGCCCCACCTGGTGGTAGCCCACACCAAGGGGACTAGA
GTGGTGGCCGCTTGGGACGAAAGGGCCTACCCCTGGCGGGAGGAGTTCCACCTCCTGCCC
AAGGAAGGTGTGAGACTGGACCCCTCGTCCCTGGTGCAGTGGTTAAACTCCGAAGCGATG
CAGAAGCACGTCAGGACGCTTTATCGCGACTTCGTGCCCCACCTGACGCTGAGGATGCTA
GAAAGGCTTCCTGTAAGGAGGGAATATGGCTTCCACACAAGCCCAGAAAGCGCTCGAAAC
TTTTGA

# Drug_Target_3_General_Function:
Involved in nucleic acid binding

# Drug_Target_3_General_References:
1551602	Barany F, Slatko B, Danzitz M, Cowburn D, Schildkraut I, Wilson GG: The corrected nucleotide sequences of the TaqI restriction and modification enzymes reveal a thirteen-codon overlap. Gene. 1992 Mar 1;112(1):91-5.
2827113	Slatko BE, Benner JS, Jager-Quinton T, Moran LS, Simcox TG, Van Cott EM, Wilson GG: Cloning, sequencing and expression of the Taq I restriction-modification system. Nucleic Acids Res. 1987 Dec 10;15(23):9781-96.
7971991	Labahn J, Granzin J, Schluckebier G, Robinson DP, Jack WE, Schildkraut I, Saenger W: Three-dimensional structure of the adenine-specific DNA methyltransferase M.Taq I in complex with the cofactor S-adenosylmethionine. Proc Natl Acad Sci U S A. 1994 Nov 8;91(23):10957-61.

# Drug_Target_3_HGNC_ID:
Not Available

# Drug_Target_3_HPRD_ID:
Not Available

# Drug_Target_3_ID:
4332

# Drug_Target_3_Locus:
Not Available

# Drug_Target_3_Molecular_Weight:
47863

# Drug_Target_3_Name:
Modification methylase TaqI

# Drug_Target_3_Number_of_Residues:
421

# Drug_Target_3_PDB_ID:
1AQJ

# Drug_Target_3_Pathway:
Not Available

# Drug_Target_3_Pfam_Domain_Function:
Not Available

# Drug_Target_3_Protein_Sequence:
>Modification methylase TaqI
MGLPPLLSLPSNSAPRSLGRVETPPEVVDFMVSLAEAPRGGRVLEPACAHGPFLRAFREA
HGTAYRFVGVEIDPKALDLPPWAEGILADFLLWEPGEAFDLILGNPPYGIVGEASKYPIH
VFKAVKDLYKKAFSTWKGKYNLYGAFLEKAVRLLKPGGVLVFVVPATWLVLEDFALLREF
LAREGKTSVYYLGEVFPQKKVSAVVIRFQKSGKGLSLWDTQESESGFTPILWAEYPHWEG
EIIRFETEETRKLEISGMPLGDLFHIRFAARSPEFKKHPAVRKEPGPGLVPVLTGRNLKP
GWVDYEKNHSGLWMPKERAKELRDFYATPHLVVAHTKGTRVVAAWDERAYPWREEFHLLP
KEGVRLDPSSLVQWLNSEAMQKHVRTLYRDFVPHLTLRMLERLPVRREYGFHTSPESARN
F

# Drug_Target_3_Reaction:
Not Available

# Drug_Target_3_Signals:
None

# Drug_Target_3_Specific_Function:
This methylase recognizes the double-stranded sequence TCGA, causes specific methylation on A-4 on both strands and protects the DNA from cleavage by the TaqI endonuclease

# Drug_Target_3_SwissProt_ID:
P14385

# Drug_Target_3_SwissProt_Name:
MTTA_THEAQ

# Drug_Target_3_Synonyms:
Adenine-specific methyltransferase TaqI
EC 2.1.1.72
M.TaqI

# Drug_Target_3_Theoretical_pI:
9.39

# Drug_Target_3_Transmembrane_Regions:
None

# Drug_Target_4_Cellular_Location:
Cytoplasmic

# Drug_Target_4_Chromosome_Location:
Not Available

# Drug_Target_4_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_4_Essentiality:
Non-Essential

# Drug_Target_4_GenAtlas_ID:
Not Available

# Drug_Target_4_GenBank_ID_Gene:
X16456

# Drug_Target_4_GenBank_ID_Protein:
46455

# Drug_Target_4_GeneCard_ID:
Not Available

# Drug_Target_4_Gene_Name:
rsrIM

# Drug_Target_4_Gene_Sequence:
>960 bp
ATGGCAAACCGATCTCACCACAATGCGGGCCACCGAGCGATGAACGCTCTCCGCAAGTCA
GGCCAAAAGCATTCGTCCGAGTCTCAGTTGGGATCTTCGGAGATCGGAACCACACGACAT
GTGTATGACGTTTGCGATTGCCTCGACACCTTGGCGAAGCTGCCCGACGACTCCGTCCAG
TTGATCATTTGTGATCCTCCATACAACATCATGCTGGCGGACTGGGATGATCACATGGAC
TACATCGGCTGGGCGAAGCGATGGCTAGCCGAAGCCGAGCGTGTTCTATCCCCAACGGGC
AGCATAGCGATTTTCGGCGGCCTACAATACCAAGGGGAGGCTGGTTCAGGTGATCTGATC
TCAATCATTTCGCACATGAGACAAAACAGCAAAATGCTGCTCGCAAACCTTATCATCTGG
AACTATCCGAACGGCATGAGTGCGCAGCGCTTCTTTGCAAATAGGCACGAGGAAATCGCG
TGGTTCGCCAAGACCAAGAAGTATTTCTTCGATCTTGACGCTGTGCGGGAACCATATGAC
GAGGAAACCAAAGCCGCTTACATGAAGGACAAGCGGTTGAACCCTGAGTCGGTTGAAAAG
GGACGCAACCCAACAAACGTGTGGCGGATGTCTCGGCTTAACGGCAATTCTCTTGAACGT
GTCGGCCACCCCACGCAAAAACCAGCCGCAGTGATTGAGAGACTGGTTCGCGCGTTGTCG
CATCCGGGTTCAACGGTCCTCGATTTTTTTGCTGGAAGTGGGGTAACGGCGCGCGTTGCA
ATTCAAGAGGGACGGAACAGCATTTGCACTGACGCCGCGCCTGTATTCAAAGAATATTAC
CAGAAGCAGCTAACTTTCCTTCAAGATGATGGACTGATCGACAAAGCGCGATCATATGAA
ATTGTTGAAGGGGCTGCGAACTTTGGTGCAGCATTGCAGCGGGGAGATGTTGCTTCATAA

# Drug_Target_4_General_Function:
Replication, recombination and repair

# Drug_Target_4_General_References:
11024175	Scavetta RD, Thomas CB, Walsh MA, Szegedi S, Joachimiak A, Gumport RI, Churchill ME: Structure of RsrI methyltransferase, a member of the N6-adenine beta class of DNA methyltransferases. Nucleic Acids Res. 2000 Oct 15;28(20):3950-61.
2602165	Stephenson FH, Greene PJ: Nucleotide sequence of the gene encoding the RsrI methyltransferase. Nucleic Acids Res. 1989 Dec 25;17(24):10503.
2690017	Kaszubska W, Aiken C, O'Connor CD, Gumport RI: Purification, cloning and sequence analysis of RsrI DNA methyltransferase: lack of homology between two enzymes, RsrI and EcoRI, that methylate the same nucleotide in identical recognition sequences. Nucleic Acids Res. 1989 Dec 25;17(24):10403-25.

# Drug_Target_4_HGNC_ID:
Not Available

# Drug_Target_4_HPRD_ID:
Not Available

# Drug_Target_4_ID:
2653

# Drug_Target_4_Locus:
Not Available

# Drug_Target_4_Molecular_Weight:
35656

# Drug_Target_4_Name:
Modification methylase RsrI

# Drug_Target_4_Number_of_Residues:
319

# Drug_Target_4_PDB_ID:
1NW7

# Drug_Target_4_Pathway:
Not Available

# Drug_Target_4_Pfam_Domain_Function:
PF01555	N6_N4_Mtase

# Drug_Target_4_Protein_Sequence:
>Modification methylase RsrI
MANRSHHNAGHRAMNALRKSGQKHSSESQLGSSEIGTTRHVYDVCDCLDTLAKLPDDSVQ
LIICDPPYNIMLADWDDHMDYIGWAKRWLAEAERVLSPTGSIAIFGGLQYQGEAGSGDLI
SIISHMRQNSKMLLANLIIWNYPNGMSAQRFFANRHEEIAWFAKTKKYFFDLDAVREPYD
EETKAAYMKDKRLNPESVEKGRNPTNVWRMSRLNGNSLERVGHPTQKPAAVIERLVRALS
HPGSTVLDFFAGSGVTARVAIQEGRNSICTDAAPVFKEYYQKQLTFLQDDGLIDKARSYE
IVEGAANFGAALQRGDVAS

# Drug_Target_4_Reaction:
S-adenosyl-L-methionine + DNA adenine = S-adenosyl-L-homocysteine + DNA 6-methylaminopurine

# Drug_Target_4_Signals:
None

# Drug_Target_4_Specific_Function:
This methylase recognizes the double-stranded sequence GAATTC, causes specific methylation on A-? on both strands, and protects the DNA from cleavage by the RsrI endonuclease

# Drug_Target_4_SwissProt_ID:
P14751

# Drug_Target_4_SwissProt_Name:
MTR1_RHOSH

# Drug_Target_4_Synonyms:
Adenine-specific methyltransferase RsrI
EC 2.1.1.72
M.RsrI

# Drug_Target_4_Theoretical_pI:
7.06

# Drug_Target_4_Transmembrane_Regions:
None

#END_DRUGCARD DB01910
